Allspring Global Investments’s Treace Medical Concepts TMCI Stock Holding History

Allspring Global Investments’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-391,079	Closed	-$5.13M	–	2722
2023 Q3	$5.13M	Sell	391,079 -419,709	-52%	-$7.68M	0.01%	966
2023 Q2	$20.7M	Buy	810,788 +141,340	+21%	+$3.65M	0.03%	587
2023 Q1	$16.9M	Buy	669,448 +190,633	+40%	+$4.48M	0.03%	650
2022 Q4	$11M	Buy	478,815 +352,208	+278%	+$8.11M	0.02%	758
2022 Q3	$2.79M	Sell	126,607 -841	-0.7%	-$16.3K	﹤0.01%	1136
2022 Q2	$1.83M	Buy	127,448 +21,243	+20%	+$358K	﹤0.01%	1257
2022 Q1	$2.01M	Buy	106,205 +13,050	+14%	+$254K	﹤0.01%	1495
2021 Q4	$1.74M	Buy	+93,155	New	+$1.92M	﹤0.01%	1618

Other funds holding TMCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's TMCI Position: Q4 2023 in Review

Allspring Global Investments sold out of Treace Medical Concepts (TMCI) in Q4 2023, closing a stake of 391,079 shares — an estimated $5.13M sold.

Allspring Global Investments first reported a position in TMCI in Q4 2021 and held it in 8 quarters. The position peaked at $20.7M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q4 2023.

Allspring Global Investments reported no remaining Treace Medical Concepts position as of Q4 2023 after selling out during the quarter.
Allspring Global Investments sold 391,079 Treace Medical Concepts shares in Q4 2023, an estimated $5.13M.
Allspring Global Investments first reported a position in Treace Medical Concepts in Q4 2021 and held it in 8 quarters.
Allspring Global Investments's Treace Medical Concepts position peaked at $20.7M in Q2 2023.
127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.